These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7115834)

  • 1. Raised endogenous monoamine oxidase inhibitor output in postwithdrawal alcoholics: effects of L-dopa and ethanol.
    Bhattacharya SK; Glover V; Sandler M; Clow A; Topham A; Bernadt M; Murray R
    Biol Psychiatry; 1982 Jul; 17(7):829-36. PubMed ID: 7115834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of salsolinol in alcohol intake and withdrawal.
    Clow A; Topham A; Saunders JB; Murray R; Sandler M
    Prog Clin Biol Res; 1985; 183():101-13. PubMed ID: 4048178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary MAO inhibitor in psychiatric illness.
    Petursson H; Reveley MA; Glover V; Sandler M
    Psychiatry Res; 1981 Dec; 5(3):335-40. PubMed ID: 6948313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The density of monoamine oxidase B sites is not altered in the postmortem brain of alcoholics.
    Maeztu AI; Ballesteros J; Callado LF; Gutiérrez M; Meana JJ
    Alcohol Clin Exp Res; 1997 Nov; 21(8):1479-83. PubMed ID: 9394121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tribulin: an endogenous monoamine oxidase inhibitor/benzodiazepine receptor ligand.
    Sandler M; Glover V; Clow A; Elsworth JD
    Prog Clin Biol Res; 1985; 192():359-62. PubMed ID: 3001762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection times for urinary ethyl glucuronide and ethyl sulfate in heavy drinkers during alcohol detoxification.
    Helander A; Böttcher M; Fehr C; Dahmen N; Beck O
    Alcohol Alcohol; 2009; 44(1):55-61. PubMed ID: 18971292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary output of endogenous monoamine oxidase inhibitor and isatin during acute migraine attacks.
    Jarman J; Przyborowska A; Glover V; Halket J; Davies PT; Rose FC; Sandler M
    J Neural Transm Gen Sect; 1991; 84(1-2):129-34. PubMed ID: 2054144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The monoamine reuptake inhibitor BTS 74 398 fails to evoke established dyskinesia but does not synergise with levodopa in MPTP-treated primates.
    Hansard MJ; Smith LA; Jackson MJ; Cheetham SC; Jenner P
    Mov Disord; 2004 Jan; 19(1):15-21. PubMed ID: 14743355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The urinary MHPG/creatinine ratio and its relationship to platelet monoamine oxidase activity in abstinent alcoholics.
    Farren CK; Tipton KF
    Addict Biol; 1999 Jan; 4(1):73-80. PubMed ID: 20575773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of L-dopa on epinephrine concentration in rat brain: possible role of inhibition of norepinephrine N-methyltransferase by S-adenosylhomocysteine.
    Fuller RW; Hemrick-Luecke SK; Perry KW
    J Pharmacol Exp Ther; 1982 Oct; 223(1):84-9. PubMed ID: 7120131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethanol and endogenous ligands in humans.
    Sandler M; Glover V; Elsworth JD; Clow A
    Psychopharmacol Bull; 1984; 20(3):485-6. PubMed ID: 6089251
    [No Abstract]   [Full Text] [Related]  

  • 12. Parkinson's disease: the effect of L-dopa therapy on urinary free catecholamines and metabolites.
    Davidson DF; Grosset K; Grosset D
    Ann Clin Biochem; 2007 Jul; 44(Pt 4):364-8. PubMed ID: 17594783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of L-DOPA uptake and decarboxylating neuronal structures in the cat brain using dopamine immunohistochemistry.
    Kitahama K; Geffard M; Araneda S; Arai R; Ogawa K; Nagatsu I; Pequignot JM
    Brain Res; 2007 Sep; 1167():56-70. PubMed ID: 17692830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A behavioral and neurochemical study on the mechanism of the anxiolytic effect of monoamine oxidase inhibitors].
    Maki Y
    Hokkaido Igaku Zasshi; 2001 May; 76(3):133-42. PubMed ID: 11481866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of salsolinol excretion in alcoholics and nonalcoholic controls.
    Feest U; Kemper A; Nickel B; Rabe H; Koalick F
    Alcohol; 1992; 9(1):49-52. PubMed ID: 1733425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced cortical dopamine output and antipsychotic-like effect of raclopride with adjunctive low-dose L-dopa.
    Eltayb A; Wadenberg ML; Svensson TH
    Biol Psychiatry; 2005 Aug; 58(4):337-43. PubMed ID: 16102547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased urinary tribulin output in generalised anxiety disorder.
    Clow A; Glover V; Sandler M; Tiller J
    Psychopharmacology (Berl); 1988; 95(3):378-80. PubMed ID: 3137625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of renal dopamine synthesis in the diuretic effect of furosemide in normohydrated rats.
    Nowicki S; Levin G; Enero MA
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1377-80. PubMed ID: 8450472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum creatinine values and changes in alcohol consumption among alcohol dependent patients.
    Keso L; Salaspuro M
    Alcohol Alcohol Suppl; 1987; 1():611-3. PubMed ID: 3426741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of ethanol consumption on the sensitivity of rat brain monoamine oxidases to the inhibition by pargyline in vivo and in vitro.
    Panova NG; Axenova LN; Medvedev AE
    Neurobiology (Bp); 2000; 8(3-4):225-30. PubMed ID: 11225512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.